PDPL logo

Parenteral Drugs (India) Ltd

PDPL·NSE·
4.25 -0.20 (-4.49%)
Market Cap11.96 Cr
PE Ratio
Volume555
Day High - Low4.25 - 4.25
52W High-Low
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Last traded ₹4.25 on 4 Dec 2022 (1368 days ago). Not a live price.
DocStoX Score
0.0/10
Poor
Fair Value
Sign in to see
ROE
P/E
Debt / Equity
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Poor

Price performance

DocStoX take

Held back by growth (0.0). The latest financials on file are more than 18 months old, so treat the fundamental measures with caution. Scored on 3 of 5 measures.

DocStoX score

Low confidence
0.0
/10
Poor
Quality
Weak
Net margin -950.0%
Valuation
No data
No valuation multiples
Growth
Flat
Revenue -48.9% 5Y CAGR
Risk
Moderate
₹12 cr market cap
Momentum
No data
No technical indicators

Scored on 3 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹12 Cr
52W High / Low
Dividend Yield
Promoter Holding
73.29%
EPS (TTM)
₹-25.61
Book Value

Key highlights

  • Revenue shrinking 49% a year
  • Loss-making in some of the last 5 years
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals & Biotechnology

Parenteral Drugs (India) Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.